1-3 of 3
Sheng-Ye Lu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Completely Oral Regimen Including Oral Etoposide As Cytoreductive Chemotherapy Combined with All Trans Retinoic Acid and Oral Arsenic for Induction Therapy in Patients with High-Risk APL：Comparable to Intravenous Cytoreductive Therapy

Feifei Tang, Wen-Bing Duan, Xiao-Hong Liu, Sheng-Ye Lu, Xiao-Su Zhao, Ya-Zhen Qin, Jin-Song Jia, Jing Wang, Li-Zhong Gong, Qian Jiang, Zhao Ting, Hong-Xia Shi, Ying-Jun Chang, Xiao-Jun Huang, Hao Jiang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4288.
https://doi.org/10.1182/blood-2023-188657
Published: 2023
Journal Articles

IL-17-Producing T Cells Contribute to Mediate Acutegraft-Versus-Disease In Patients Undergoing Unmanipulated Blood and MarrowTransplantation

Xiang-Yu Zhao, Ling-Ling Xu, Sheng-Ye Lu, Kai-Yan Liu, Lan-Ping Xu, Dai-Hong Liu, Xiao Jun Huang
Journal: Blood
Blood (2010) 116 (21): 2310.
https://doi.org/10.1182/blood.V116.21.2310.2310
Published: 2010
Journal Articles

CD4 + CD25 - CD69 + t Cells Is a Novel Subset of Regulatory T Cells Involved In the Prevention of Acute Graft-Versus-Host Disease In Human

Sheng-Ye Lu, Ph.D., candidate, Xiao Jun Huang, M.D, Kai-Yan Liu, M.D, and, PhD, Dai-Hong Liu, M.D, and, PhD, Lan-Ping Xu, M.D
Journal: Blood
Blood (2010) 116 (21): 1250.
https://doi.org/10.1182/blood.V116.21.1250.1250
Published: 2010